ProPhase Labs, Inc. (PRPH) Earnings History
Net Loss30 years of earnings data (1996–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
ProPhase Labs, Inc. (PRPH) Earnings Overview
As of June 22, 2026, ProPhase Labs, Inc. (PRPH) reported trailing twelve-month net income of -$15M, reflecting +93.3% year-over-year growth. The company earned $-1.74 per diluted share over the past four quarters, with a net profit margin of -339.3%.
Looking at the long-term picture, PRPH's historical earnings data spans multiple years. The company achieved its highest annual net income of $42M in fiscal 2017.
ProPhase Labs, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including QDEL (-$1.21B net income, -41.5% margin), CLOV (-$57M net income, -4.4% margin), BNGO (-$32M net income, -92.6% margin), PRPH has room to improve margins relative to the peer group. Compare PRPH vs QDEL →
PRPH Earnings vs Peers
Earnings metrics vs comparable public companies
PRPH Historical Earnings Data (1996–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$15M | +72.4% | -$18M | $-1.74 | -339.3% | -415.4% |
| 2024 | -$53M | -218.0% | -$39M | $-26.10 | -788.2% | -570.6% |
| 2023 | -$17M | -190.9% | -$22M | $-9.80 | -37.8% | -48.7% |
| 2022 | $18M | +194.3% | $24M | $10.20 | 15.1% | 19.2% |
| 2021 | $6M | +395.2% | $10M | $4.00 | 7.9% | 12.4% |
| 2020 | -$2M | +32.5% | -$4M | $-2.00 | -14.6% | -27.4% |
| 2019 | -$3M | -80.8% | -$3M | $-2.60 | -31.9% | -32.8% |
| 2018 | -$2M | -104.2% | -$2M | $-1.50 | -13.3% | -12.4% |
| 2017 | $42M | +1558.5% | -$4M | $25.90 | 423.9% | -40.4% |
| 2016 | -$3M | +20.3% | -$3M | $-1.70 | -13.6% | -12.6% |
| 2015 | -$4M | +54.0% | -$4M | $-2.20 | -17.5% | -17.4% |
| 2014 | -$8M | -2034.3% | -$8M | $-4.70 | -35.5% | -35.5% |
| 2013 | $405,000 | +137.1% | $416,000 | $0.30 | 1.6% | 1.7% |
| 2012 | -$1M | +59.7% | -$1M | $-0.73 | -4.9% | -4.9% |
| 2011 | -$3M | +22.6% | -$3M | $-1.80 | -15.5% | -15.7% |
| 2010 | -$4M | +8.9% | -$4M | $-2.50 | -24.1% | -24.8% |
| 2009 | -$4M | +30.6% | -$4M | $-3.00 | -19.4% | -19.9% |
| 2008 | -$6M | -125.1% | -$7M | $-4.30 | -27.0% | -32.8% |
| 2007 | -$2M | -40.6% | -$3M | $-1.90 | -6.2% | -8.2% |
| 2006 | -$2M | -154.4% | -$2M | $-1.40 | -4.2% | -5.7% |
| 2005 | $3M | +610.3% | $3M | $2.40 | 6.0% | 5.6% |
| 2004 | $452,862 | -32.9% | $181,987 | $0.30 | 1.0% | 0.4% |
| 2003 | $674,574 | +110.5% | $635,538 | $0.50 | 1.6% | 1.5% |
| 2002 | -$6M | -3088.7% | -$5M | $-5.90 | -21.9% | -18.0% |
| 2001 | $215,964 | +104.2% | $-425,997 | $0.20 | 0.9% | -1.7% |
| 2000 | -$5M | -23.7% | -$6M | $-4.90 | -26.8% | -30.6% |
| 1999 | -$4M | -161.8% | -$7M | $-3.70 | -16.9% | -28.2% |
| 1998 | $7M | -67.6% | $10M | $4.60 | 18.7% | 26.6% |
| 1997 | $21M | +3100.0% | $35M | $14.30 | 29.9% | 50.3% |
| 1996 | $-700,000 | - | $-700,000 | $-0.55 | -87.5% | -87.5% |
Download Data
Export PRPH earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRPH — Frequently Asked Questions
Quick answers to the most common questions about buying PRPH stock.
What is PRPH earnings per share (EPS)?
PRPH trailing twelve-month (TTM) diluted EPS is $-1.74, reflecting +93.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1996 to 2025 is available in the table on this page.
What is ProPhase Labs, Inc.'s net income?
ProPhase Labs, Inc. (PRPH) trailing twelve-month net income is $-15M as of 2025. Earnings grew +93.3% year-over-year.
Is PRPH profitable?
PRPH is not currently profitable on a TTM basis, reporting a net loss of $-15M. Net margin is -339.3%. Investors should monitor for a return to profitability.
What is PRPH's earnings growth rate?
PRPH compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1996 to 2025.
What are PRPH's profit margins?
ProPhase Labs, Inc. net profit margin is -339.3%, operating margin is -415.4%, and gross margin is +31.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is -271.5%.
Is PRPH growing earnings?
Yes, PRPH earnings are accelerating — EPS growth of +93.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-15M. Earnings momentum is strengthening.
What was PRPH's best earnings year?
ProPhase Labs, Inc.'s highest annual net income on record is $42M, achieved in fiscal year 2017. Earnings history on this page spans 1996 to 2025 and includes all annual and quarterly figures.
What were PRPH's earnings last quarter?
PRPH's most recent reported quarter was Q4 2025. Net income was $-7M with diluted EPS of $-0.87. For a full breakdown of all quarters, see the quarterly earnings table on this page.